Author: SimBioSys

Business

SimBioSys Secures Third FDA Clearance for TumorSight™ Viz, Advancing AI-Powered Precision Surgery in Breast Cancer Care

July 11, 2025
SimBioSys
No Comments

Latest release introduces industry-leading AI performance, optimized workflow integration, and enhanced surgeon usability to streamline imaging-to-intervention planning , /PRNewswire/ — SimBioSys®, a clinical AI company…